Posted in Antibodies, Assay Kits, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, DNA Testing, Elisa Kits, PCR, Peptides, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits
Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report
Mother’s infarction (MFI) and Masif Fibrin Perive (MPFD) deposition (MPFD) are unusual, related to the condition of the secondary placenta of trophoblastic cell damage. The etiology is unknown but MPFD / MFI is associated with adverse obstetric results and a significant risk of repeatment. Case Report: We report the MPFD / MFI case related to placentitis Cytomegalovirus (CMV). A 27-year-old mother gave birth to a man’s fetus born with a postmortem diagnosis of default CMV.
The placenta shows limfohistiocial villitis with isolated CMV inclusion, in combination with MFI. Villitis has an intermediary feature between unclean cmv placentitis and ethiological villitis (Vue). Conclusion: Vue is considered a reaction of an anti-fetal immune mother who resembles the refusal of allograft. We postulate that viral infections in our case may have triggered this immune response, considering that CMV antigens are known to be crossing with some human antigens, especially HLA. The next trophoblastic cell damage can then lead to MFI / MFPD.
Hemolytic uremic syndrome and atypical nephrotic syndrome associated with cytomegalovirus infection
Atypical hemolytic uremic syndrome (ahus) is a rare disease. It is produced from the disregulation of alternative complementary pathways on the cell surface which causes endothelial damage. Increasing evidence evidence, this disorder is for mutations in the complementary regulator gene or with autoantibodies to complementary factors. This mutation has incomplete penetration and variable phenotypes.
Cytomegalovirus (CMV) is endemic throughout the world, and the incidence of severe CMV disease in immunocompetent adults seems to be greater than previously thought. Ahus and nephrotic syndrome associated with CMV infection rarely occur. The identification of triggers for the manifestation of the ahus in patients who are vulnerable genetics is very important because this allows faster clinical treatment and improvement initiations. We reported a case of a man with the removal of homozygous CFHR3-1 whose initial presentation was ahus and nephrotic syndrome associated with CMV infection.
IgA binds epitop glycoprotein B and neutralizes human cytomegalovirus
Human Cytomegalovirus (HCMV) is a pathogen everywhere that has the potential for pathogens in immunosuppression individuals and pregnant women during primary infections. HCMV Envelope Glycoprotein B (GB) facilitates virus entries into all types of cells and induces strong immune responses. Epitope AD-2 is a very preserved GB Linear GB epitope and the critical target for antibodies, only 50% of seropositive individuals that make IgG antibodies to this site and the rib response has not been fully investigated.
This study aims to compare IGG and IGA responses to GB and Epitop AD-2 in individuals who are exposed to naturally and those who receive the recombinant Ajuvant GB / MF59 vaccine. Thus, seropositive individual vaccination increases the existing IGA and GB IGG levels and induces the rib response and specific IGG de Novo GB on seronegative receivers. The existing IgG response and AD-2 ribs were driven by vaccination but the response of De Novo AD-2 was not detected. Individuals exposed naturally have the dominant IgG response to GB and AD-2 compared to weaker rib responses and variables, although significant rib response to AD-2 was observed in the ASI ASI sample.
All antibodies tie the AD-2 contain a light chain of kappa while the use of a balanced capa / lambda light chain is found for those who bind to GB. The V-region matches the specific recombinant IGG AD-2 and ribs are bound to GB and AD-2 and neutralize HCMV infection in vitro. Overall, this result shows that even though the human IGG response dominates, class IGA antibodies against AD-2 are significant components of breast milk that can function to protect neonates from HCMV.
Cytomegalovirus After a kidney transplant in 2020: moving towards personalized prevention
Cytomegalovirus (CMV) – Close complications after kidney transplants remain a substantial challenge. Instead of applying a preventive strategy to all risky patients, we can now adjust our strategies at the individual patient level. The prophylaxis of antivirus or strict pre-emptive strategies may be optimal for patients with the highest risk for CMV, while lower risk patients can be profitable especially from pre-emptive monitoring and therapeutic administration only if needed.
CMV Special T-Testing may be useful to improve the determination of CMV risk in pre-transplants, and to guide decisions about the need for antivirus therapy or duration. Immunosupressive regimens including the target of the Rapamycin mammal inhibitor reduces the risk of CMV and thus can be an interesting choice in some patients. The new antivirus agent further expanded our therapy arsenal in the near future, and the prospect of CMV vaccination and remove cell therapy seems to be on the horizon.

Cytomegalovirus Pre-Transplant Immunity and Risk of Viral Reactivation After Lung Transplantation: Prospective Cohort Study
Cytomegalovirus (CMV) remains a significant burden on the recipient of the lung transplant. Disadvantages in the immunity of the TP-transplant increases the risk of complications related to CMV. However, it is not clear if the underlying pre-transplant immunity increases risk. To assess this, we recruit 39 lung transplant patients and do quantiferon-CMV in their peripheral blood. More than a third of prospective cmv-seropositive transplant receivers are non-imun-reactive CMV (CMV-NIR) pre-transplant.
Hba Polyclonal Antibody |
A53679 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: The best epigenetics products |
Anti-HBA antibody |
STJ192419 |
St John's Laboratory |
200 µl |
EUR 197 |
Description: Unconjugated Rabbit polyclonal to HBA |
HBA Polyclonal Antibody |
ES11261-100ul |
ELK Biotech |
100ul |
EUR 279 |
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
HBA Polyclonal Antibody |
ES11261-50ul |
ELK Biotech |
50ul |
EUR 207 |
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Hba Antibody, HRP conjugated |
1-CSB-PA010147LB01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA |
Hba Antibody, FITC conjugated |
1-CSB-PA010147LC01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA |
Hba Antibody, Biotin conjugated |
1-CSB-PA010147LD01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Human Brain Astrocytes (HBA) |
HMP202 |
Neuromics |
500,000+ cells - Frozen |
EUR 1080 |
Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6915803 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3179403 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3332403 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3266403 |
ABM |
1.0 ug DNA |
EUR 154 |
Mouse Hemoglobin subunit alpha (Hba) |
1-CSB-YP010147MO |
Cusabio |
-
EUR 504.00
-
EUR 265.00
-
EUR 1832.00
-
EUR 763.00
-
EUR 1216.00
-
EUR 334.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in Yeast |
Mouse Hemoglobin subunit alpha (Hba) |
1-CSB-EP010147MO |
Cusabio |
-
EUR 505.00
-
EUR 265.00
-
EUR 1827.00
-
EUR 766.00
-
EUR 1218.00
-
EUR 335.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in E.coli |
Hba-a2 Recombinant Protein (Rat) |
RP204248 |
ABM |
100 ug |
Ask for price |
Hba-a1 Recombinant Protein (Mouse) |
RP140990 |
ABM |
100 ug |
Ask for price |
Hba-a2 Recombinant Protein (Mouse) |
RP140993 |
ABM |
100 ug |
Ask for price |
Hba-x Recombinant Protein (Mouse) |
RP140996 |
ABM |
100 ug |
Ask for price |
Hemoglobin Subunit Alpha (Hba) Antibody |
20-abx109857 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
Hba Polyclonal Antibody, HRP Conjugated |
A53680 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: kits suitable for this type of research |
Hba Polyclonal Antibody, FITC Conjugated |
A53681 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: fast delivery possible |
Hba Polyclonal Antibody, Biotin Conjugated |
A53682 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: reagents widely cited |
HBA ELISA Kit (Bovine) (OKEH03848) |
OKEH03848 |
Aviva Systems Biology |
96 Wells |
EUR 779 |
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues.;Species reactivity: Bovine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.59 ng/mL |
HBA ELISA Kit (Mouse) (OKEH05810) |
OKEH05810 |
Aviva Systems Biology |
96 Wells |
EUR 662 |
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.84 ng/mL |
Rat Hemoglobin subunit alpha-1/2, HBA ELISA Kit |
ELA-E0517r |
Lifescience Market |
96 Tests |
EUR 886 |
Hba-a2 ORF Vector (Rat) (pORF) |
ORF068084 |
ABM |
1.0 ug DNA |
EUR 506 |
Hba-a1 ORF Vector (Mouse) (pORF) |
ORF046998 |
ABM |
1.0 ug DNA |
EUR 506 |
Hba-a2 ORF Vector (Mouse) (pORF) |
ORF046999 |
ABM |
1.0 ug DNA |
EUR 506 |
Hba-x ORF Vector (Mouse) (pORF) |
ORF047000 |
ABM |
1.0 ug DNA |
EUR 506 |
Human Anti-Influenza B virus IgA ELISA kit, 96 tests, Quantitative |
920-410-HBA |
Alpha Diagnostics |
1 Kit |
EUR 712 |
Human Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E05171h |
Lifescience Market |
96 Tests |
EUR 824 |
Bovine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517b |
Lifescience Market |
96 Tests |
EUR 928 |
Chicken Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517c |
Lifescience Market |
96 Tests |
EUR 928 |
Canine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517d |
Lifescience Market |
96 Tests |
EUR 928 |
Mouse Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517m |
Lifescience Market |
96 Tests |
EUR 865 |
Porcine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517p |
Lifescience Market |
96 Tests |
EUR 928 |
Hba-a2 sgRNA CRISPR Lentivector set (Rat) |
K6915801 |
ABM |
3 x 1.0 ug |
EUR 339 |
Hba-a2 sgRNA CRISPR Lentivector set (Mouse) |
K3179401 |
ABM |
3 x 1.0 ug |
EUR 339 |
Hba-a1 sgRNA CRISPR Lentivector set (Mouse) |
K3332401 |
ABM |
3 x 1.0 ug |
EUR 339 |
Hba-x sgRNA CRISPR Lentivector set (Mouse) |
K3266401 |
ABM |
3 x 1.0 ug |
EUR 339 |
Bovine HBA/ Hemoglobin subunit alpha ELISA Kit |
E0304Bo |
Sunlong |
1 Kit |
EUR 717 |
2-Propyl-β-D-glucuronide, 2 mg |
0904-2 |
AthenaES |
2 mg |
EUR 162 |
Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6915807 |
ABM |
1.0 ug DNA |
EUR 167 |
Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3179407 |
ABM |
1.0 ug DNA |
EUR 167 |
Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3332407 |
ABM |
1.0 ug DNA |
EUR 167 |
Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3266407 |
ABM |
1.0 ug DNA |
EUR 167 |
IL-2 Interleukin-2 Human Recombinant Protein, His Tag |
PROTP60568-2 |
BosterBio |
Regular: 10ug |
EUR 317 |
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_ |
BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer |
PROTP12643-2 |
BosterBio |
Regular: 20ug |
EUR 317 |
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques. |
Individual Reaction Mix 2 |
G065-2 |
ABM |
200 reactions |
EUR 167 |
PG LIVER 2 EA* |
59423-2 |
Pel-Freez |
2 EA |
EUR 192.24 |
Hba-a1 3'UTR Luciferase Stable Cell Line |
TU109375 |
ABM |
1.0 ml |
Ask for price |
Hba-a2 3'UTR Luciferase Stable Cell Line |
TU109376 |
ABM |
1.0 ml |
Ask for price |
Hba-x 3'UTR Luciferase Stable Cell Line |
TU109377 |
ABM |
1.0 ml |
Ask for price |
Hba-a2 3'UTR Luciferase Stable Cell Line |
TU205653 |
ABM |
1.0 ml |
Ask for price |
Hba-a1 3'UTR GFP Stable Cell Line |
TU159375 |
ABM |
1.0 ml |
Ask for price |
Hba-a2 3'UTR GFP Stable Cell Line |
TU159376 |
ABM |
1.0 ml |
Ask for price |
Hba-x 3'UTR GFP Stable Cell Line |
TU159377 |
ABM |
1.0 ml |
Ask for price |
Hba-a2 3'UTR GFP Stable Cell Line |
TU255653 |
ABM |
1.0 ml |
Ask for price |
Hba-a2 Protein Vector (Rat) (pPB-C-His) |
PV272334 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Rat) (pPB-N-His) |
PV272335 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Rat) (pPM-C-HA) |
PV272336 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Rat) (pPM-C-His) |
PV272337 |
ABM |
500 ng |
EUR 603 |
Hba-a1 Protein Vector (Mouse) (pPB-C-His) |
PV187990 |
ABM |
500 ng |
EUR 603 |
Hba-a1 Protein Vector (Mouse) (pPB-N-His) |
PV187991 |
ABM |
500 ng |
EUR 603 |
Hba-a1 Protein Vector (Mouse) (pPM-C-HA) |
PV187992 |
ABM |
500 ng |
EUR 603 |
Hba-a1 Protein Vector (Mouse) (pPM-C-His) |
PV187993 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Mouse) (pPB-C-His) |
PV187994 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Mouse) (pPB-N-His) |
PV187995 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Mouse) (pPM-C-HA) |
PV187996 |
ABM |
500 ng |
EUR 603 |
Hba-a2 Protein Vector (Mouse) (pPM-C-His) |
PV187997 |
ABM |
500 ng |
EUR 603 |
Hba-x Protein Vector (Mouse) (pPB-C-His) |
PV187998 |
ABM |
500 ng |
EUR 603 |
Hba-x Protein Vector (Mouse) (pPB-N-His) |
PV187999 |
ABM |
500 ng |
EUR 603 |
Hba-x Protein Vector (Mouse) (pPM-C-HA) |
PV188000 |
ABM |
500 ng |
EUR 603 |
Hba-x Protein Vector (Mouse) (pPM-C-His) |
PV188001 |
ABM |
500 ng |
EUR 603 |
Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6915802 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6915804 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3179402 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3179404 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3332402 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3332404 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3266402 |
ABM |
1.0 ug DNA |
EUR 154 |
Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3266404 |
ABM |
1.0 ug DNA |
EUR 154 |
Dr. P Kit-Solution 2 |
K2021010-2 |
Biochain |
6 ml |
EUR 120 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
Anti-ErbB 2/ERBB2 Antibody |
A00010-2 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Bcl-2/BCL2 Antibody |
A00040-2 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Angiopoietin-2/ANGPT2 Antibody |
A00370-2 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-EIF4A1/2/3 Antibody |
A03922-2 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Fascin 2/FSCN2 Antibody |
A07840-2 |
BosterBio |
100ug/vial |
EUR 294 |
Bovine KIDNEY WHOLE 2 EA* |
57120-2 |
Pel-Freez |
2 EA |
EUR 174.84 |
Recombinant Human TFF-2 Protein |
PROTQ03403-2 |
BosterBio |
20ug |
EUR 317 |
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 107 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds. |
Recombinant Human Relaxin-2 Protein |
PROTP04090-2 |
BosterBio |
25ug |
EUR 317 |
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain. |
Recombinant Murine IL-2 Protein |
PROTP04351-2 |
BosterBio |
20ug |
EUR 317 |
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues. |
Recombinant Human PAI-2 Protein |
PROTP05120-2 |
BosterBio |
10ug |
EUR 317 |
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
Recombinant Human MMP-2 Protein |
PROTP08253-2 |
BosterBio |
10ug |
EUR 317 |
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids). |
Mouse FGF-2 Recombinant Protein |
R00121-2 |
BosterBio |
5ug/vial |
EUR 259 |
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast. |
Chicken IL-2 Recombinant Protein |
R00387-2 |
BosterBio |
5ug/vial |
EUR 259 |
Description: Interleukin-2 (IL-2) is a cytokine produced by T-helper cells in response to antigenic or mitogenic stimulation. It is required for T-cell proliferation and other activities crucial to the regulation of the immune response. Chicken IL-2 Recombinant Protein is purified interleukin-2 produced in yeast. |
Recombinant Human BD-2 Protein |
PROTO15263-2 |
BosterBio |
20ug |
EUR 317 |
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues. |
Ethyl-β-D-glucuronide, 2 mg |
0901-2 |
AthenaES |
2 mg |
EUR 162 |
Ethyl sulfate, sodium salt, 2 mg |
0902-2 |
AthenaES |
2 mg |
EUR 69 |
Propyl-β-D-glucuronide, 2 mg |
0903-2 |
AthenaES |
2 mg |
EUR 162 |
Anti-COX2/Cyclooxygenase 2/PTGS2 Antibody |
A00084-2 |
BosterBio |
100ug/vial |
EUR 294 |
The CMV-NIR status is associated with the incidence of CMV reactivation transplantation which is significantly higher, indicating that the immunity of CMV dysfunctional in prospective lung transplant recipients is associated with an increased risk of viral viral-transplant reactivation.
Keywords: cytomegalovirus; T-cell immunity; solid organ transplant; Virus reactivation.